Background::
Streptococcus equi ssp. zooepidemicus (SEZ) is one important pathogen.
There are still sporadic outbreaks in China, northern United States and the Netherlands. Adenylosuccinate
synthetase PurA, a newly discovered protein in prior research, requires further assessment
of its protective effectiveness.
Methods::
In this study, we focused on the expression of recombinant PurA from SEZ ATCC
35246. We evaluated the immunoreactivity of this recombinant protein using convalescent minipig
sera. Additionally, we conducted experiments in mice to assess its immunogenic properties.
Results::
Our findings revealed that the recombinant PurA triggered a substantial antibody response
in mice, resulting in an 80% protection rate against SEZ infection. Notably, mice immunized
with PurA exhibited significantly reduced bacterial colonization in all organs compared to
the PBS control group. Furthermore, the levels of IL-6, IL-8, IL-1β, and TNF-α in mouse serum
were significantly elevated in the PurA-immunized group compared to the control group. Hyperimmune
sera targeting PurA effectively eliminated SEZ in bactericidal tests. Remarkably, antibodies
against PurA demonstrated a significant inhibitory effect on developing SEZ biofilm.
Conclusion::
Immunization with PurA elicited robust humoral and cellular immune responses in
mice. These promising results suggest the potential utility of PurA in developing SEZ vaccine immunogens,
providing a valuable avenue for further research into SEZ infection prevention and control.